Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer.

Jung Rae Cho Keun-Wook Lee Heung-Kwon Oh Jin Won Kim Ji-Won Kim Duck-Woo Kim Jee Hyun Kim Sung-Bum Kang

Published in: Annals of surgical treatment and research (2022)

In high-risk stage II colon cancer, adjuvant oral fluoropyrimidine monotherapy can be an effective and convenient alternative to intravenous fluoropyrimidine-based chemotherapy as it has comparable oncological outcomes and reduced chemotherapy-related complications.

Keyphrases

locally advanced
combination therapy
open label
rectal cancer
randomized controlled trial
systematic review
early stage
high dose
risk factors
type diabetes
radiation therapy
clinical trial
chemotherapy induced
study protocol
minimally invasive
weight loss